Intensity of treatment in Swiss cancer patients at the end-of-life
Authors:
Open Access
- 1 March 2018
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 10, 481-491
Abstract
Purpose: Current evidence on the care-delivering process and the intensity of treatment at the end-of-life of cancer patients is limited and remains unclear. Our objective was to examine the care-delivering processes in health care during the last months of life with real-life data of Swiss cancer patients. Patients and methods: The study population consisted of adult decedents in 2014 who were insured at Helsana Group. Data on the final cause of death were provided additionally by the Swiss Federal Statistical Office. Of the 10,275 decedents, 2,710 (26.4%) died of cancer. Intensity of treatment and health care utilization (including transitions) at their end-of-life were examined. Intensity measures included the following: last dose of chemotherapy within 14 days of death, a new chemotherapy regimen starting 14 days in hospital in the last month, death in an acute care hospital, more than one emergency visit and ≥1 intensive care unit admission in the last month of life. Results: In the last 6 months of life, 89.5% of cancer patients had ≥1 transition, with 87.2% being hospitalized. Within 30 days before death, 64.2% of the decedents had ≥1 intensive treatment, whereby 8.9% started a new chemotherapy. In the multinomial logistic regression model, older age, higher density of nursing home beds and home care nurses were associated with a decrease, while living in the Italian- or French-speaking part of Switzerland was associated with an increase in intensive care. Conclusion: Swiss cancer patients insured by Helsana Group experience a considerable number of transitions and intensive treatments at the end-of-life, whereby treatment intensity declines with increasing age. Among others, increased home care nursing might be helpful to reduce unwarranted treatments and transitions, therefore leading to better care at the end-of-life.Keywords
This publication has 49 references indexed in Scilit:
- Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medicationsBMC Public Health, 2013
- Patient–provider communication data: linking process and outcomes in oncology careCancer Management and Research, 2011
- Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care populationCancer Management and Research, 2011
- Trends in the Aggressiveness of End-of-Life Cancer Care in the Universal Health Care System of Ontario, CanadaJournal of Clinical Oncology, 2011
- Development and Validation of Hospital “End-of-Life” Treatment Intensity MeasuresMedical Care, 2009
- Comparison of Prospective and Retrospective Indicators of the Quality of End-of-Life Cancer CareJournal of Clinical Oncology, 2008
- Comparing Hospice and Nonhospice Patient Survival Among Patients Who Die Within a Three-Year WindowJournal of Pain and Symptom Management, 2007
- The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysisPsycho-Oncology, 2007
- Medicare cost in matched hospice and non-hospice cohortsJournal of Pain and Symptom Management, 2004
- Pattern of Care at the End of Life: Does Age Make a Difference in What Happens to Women With Breast Cancer?Journal of Clinical Oncology, 2004